Positive Findings on 18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer and PSA levels ≤ 0.5 and ≤ 0.3 ng/ml

被引：3
|
作者：
Lovec, P. [1 ,2 ]
Savir-Baruch, B. [1 ]
Gupta, G. [1 ]
Wagner, R. [1 ]
Gabriel, M. S. [1 ]
Harkenrider, M. M. [1 ]
Solanki, A. A. [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[2] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1001
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL
    Garza, Daniel
    Kandathil, Asha
    Xi, Yin
    Subramaniam, Rathan M.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (08) : 907 - 913
  • [2] Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels
    Marcus, Charles
    Abiodun-Ojo, Olayinka A.
    Jani, Ashesh B.
    Schuster, David M.
    [J]. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 406 - 414
  • [3] Diagnostic performance of 18F-fluciclovine PET/CT in prostate cancer patients with rising PSA level ≤ 0.5 ng/ml after multiple treatment failures
    Teyateeti, Ajalaya
    Teyateeti, Achiraya
    Ravizzini, Gregory C.
    Xu, Guofan
    Tang, Chad
    Tu, Shi-ming
    Macapinlac, Homer A.
    Lu, Yang
    [J]. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (02): : 87 - 98
  • [4] Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL
    El Bulbul, Jad
    Grybowski, Damian
    Lovrec, Petra
    Solanki, Abhishek A.
    Gabriel, Medhat S.
    Wagner, Robert H.
    Savir-Baruch, Bital
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (01) : 42 - 49
  • [5] Solitary Penile Metastasis of Prostate Cancer on 18F-Fluciclovine PET/CT Imaging in a Patient With PSA of 1 ng/mL
    Salavati, Ali
    Schik, Allyssa N.
    Koksel, Yasemin
    Gencturk, Mehmet
    Froelich, Jerry W.
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : 389 - 391
  • [6] Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL
    Jad El Bulbul
    Damian Grybowski
    Petra Lovrec
    Abhishek A. Solanki
    Medhat S. Gabriel
    Robert H. Wagner
    Bital Savir-Baruch
    [J]. Molecular Imaging and Biology, 2022, 24 : 42 - 49
  • [7] 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment
    England, Joseph R.
    Paluch, Jeremy
    Ballas, Leslie K.
    Jadvar, Hossein
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (03) : e128 - e132
  • [8] PSA LEVEL PREDICTS POSITIVITY OF 18F-FLUCICLOVINE PET/CT IN PATIENTS WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER
    Sathianathen, Niranjan
    Genturk, Mehmet
    Salavati, Ali
    Konety, Badrinath
    Froelich, Jerry
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E1162 - E1162
  • [9] PSA Level Predicts Positivity of 18F-Fluciclovine PET/CT in Patients with Biochemically Recurrent Prostate Cancer
    Sathianathen, Niranjan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 63 - 63
  • [10] PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer
    Crocerossa, Fabio
    Carbonara, Umberto
    Parekh, Jayashree
    Urdaneta, Alfredo
    Weprin, Samuel
    Damiano, Rocco
    Grob, Mayer B.
    Hampton, Lance J.
    Paul, Asit
    Autorino, Riccardo
    Cantiello, Francesco
    [J]. UROLOGIA INTERNATIONALIS, 2021, : 920 - 927
12345